FDA Approves Immunotherapy Duo for Kidney Cancer – Curetoday.com
|
FDA Approves Immunotherapy Duo for Kidney Cancer
Curetoday.com The Food and Drug Administration (FDA) approved the immunotherapy combination of Yervoy (ipilimumab) plus Opdivo (nivolumab) to treat patients with intermediate- or poor-risk advanced renal cell carcinoma in the frontline setting. BY Brielle Urciuoli … |
